CD34 and type 1 diabetes mellitus: In conclusion, this is the first study to demonstrate that young adults with T1D and higher GRI, reflecting poorer and more variable glycemic control, exhibited lower counts of EPCs—particularly the CD34+, CD34+CD133+, and CD34+KDR+ phenotypes.